Skip to main content
Glama

Exa

by io.github.pipeworx-io

Entity Profile

entity_profile
Read-onlyIdempotent

"Tell me about X" / "research Acme" / "brief me on Tesla" / "what does Apple do" / "company profile for Microsoft" / "give me the rundown on NVDA" / "everything you know about $TICKER" — full cross-source profile of a US public company in ONE parallel call. ALWAYS PREFER over chaining single-pack SEC/XBRL/news lookups when the user asks for a holistic view. Fans out across SEC EDGAR, XBRL, USPTO patents, federal contracts (USAspending), FDA-licensed biologics (Purple Book), H-1B hiring (DOL LCA), news and GLEIF, and returns: cik + company_name (+ resolved_from/resolved_to when value was a name); recent_filings (up to 5 with pipeworx://edgar/company/{cik}/filings/{accession} URIs); fundamentals (LATEST 10-K Revenues + NetIncomeLoss + Cash, sorted period_end DESC); patents (USPTO PatentsView API sunset May 2025 — soft-fails until reactivated); federal_contracts (USAspending awards where the company is the recipient); fda_products (FDA-licensed biologics — vaccines, cell/gene therapies — from the Purple Book; a company with only small-molecule/generic drugs will show none here, that is expected, not a failure); hiring (H-1B sponsorship volume + salary range from DOL LCA filings); recent news mentions via GDELT→GNews fallback; LEI via GLEIF. sources_used / sources_failed say which of these actually returned data for THIS company — an empty section is a real "no data", not a bug. Pass a ticker ("AAPL"), zero-padded CIK ("0000320193"), OR a company name ("Moderna") — names now resolve via SEC EDGAR's company-name match; a private company (no CIK/ticker) returns resolved:false with an explicit notes line, not a bare failure. type accepts "company" or "ticker" interchangeably — both take the same value shapes above.

Input Schema

TableJSON Schema
NameRequiredDescriptionDefault
typeYes"company" or "ticker" — both are accepted and behave identically; `value` can be a ticker, CIK, or company name either way. person/place coming soon.
valueYesTicker (e.g., "AAPL"), zero-padded CIK (e.g., "0000320193"), or company name (e.g., "Moderna") — names resolve via SEC EDGAR company-name match.

Schema Changelog

Changes observed during successful MCP inspections. Dates show when Glama detected each change.

  1. Changed3 schema fields changed
    • changedInput schema / properties / type / description
      Previous value: -"Entity type. Only \"company\" supported today; person/place coming soon."New value: +"\"company\" or \"ticker\" — both are accepted and behave identically; `value` can be a ticker, CIK, or company name either way. person/place coming soon."
    • changedInput schema / properties / type / enum
      Previous value: -[
-  "company"
-]New value: +[
+  "company",
+  "ticker"
+]
    • changedInput schema / properties / value / description
      Previous value: -"Ticker (e.g., \"AAPL\") or zero-padded CIK (e.g., \"0000320193\"). Names not supported — use resolve_entity first if you only have a name."New value: +"Ticker (e.g., \"AAPL\"), zero-padded CIK (e.g., \"0000320193\"), or company name (e.g., \"Moderna\") — names resolve via SEC EDGAR company-name match."
  2. First observed

TDQS

A4.8/5.0
Behavior5/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

Annotations already declare readOnlyHint, openWorldHint, idempotentHint, and destructiveHint=false, so the safety profile is covered. The description adds substantial behavioral context beyond that: it fans out in parallel across multiple data sources and returns sources_used/sources_failed so the caller can distinguish 'no data' from failure. It also discloses the zero-padded CIK requirement, name resolution behavior, private-company resolved:false behavior, and FDA 'none is expected' behavior. That goes well beyond what annotations convey.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness3/5

Is the description appropriately sized, front-loaded, and free of redundancy?

The description is information-dense but long and somewhat sprawling, with a dense run-on sentence listing data sources followed by parentheticals. It front-loads usage triggers well, but the middle section buries the input-shape clarity under a long fan-out enumeration. Every sentence earns its place, but the structure is not crisp; the parenthetical pile-up makes it harder to scan than it should be.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness5/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

Despite having no output schema, the description covers the main output sections (cik, company_name, resolved_from/resolved_to, recent_filings, fundamentals, patents, contracts, FDA products, hiring, news, LEI, sources_used/sources_failed, resolved flag, notes). It explains what to expect when data is absent, how to pass each input form, and why an empty section is a real 'no data'. For a tool of this complexity, little is missing.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters5/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Schema coverage is 100%, and the description still adds value by explaining that type accepts 'company' or 'ticker' interchangeably and that value can be a ticker, CIK, or company name regardless of type. It clarifies that names resolve via SEC EDGAR, that CIKs should be zero-padded, and that private companies yield a structured resolved:false result rather than an error. This is meaningful enrichment over the schema rather than mere repetition.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

The description opens with concrete natural-language triggers and states an explicit verb-resource pair: 'full cross-source profile of a US public company in ONE parallel call.' It distinguishes itself from sibling lookups by naming the fan-out targets (SEC EDGAR, XBRL, USPTO, etc.) and by explicitly saying to prefer it over single-pack lookups for holistic views. That is specific enough to separate it from search, resolve_entity, compare_entities, and deep_research.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines5/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

The description explicitly tells the agent when to prefer this tool ('ALWAYS PREFER over chaining single-pack SEC/XBRL/news lookups when the user asks for a holistic view') and lists accepted input forms (ticker, CIK, company name). It also defines the not-a-failure cases: private companies return resolved:false with notes, and small-molecule-only companies may show no FDA products, which is expected. This is strong routing guidance with both positive and negative use conditions.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

All Exa toolsInspect
Try in Browser
RayrunBuild, deploy, and operate MCP servers without becoming an infrastructure team.ray.runAd

Glama MCP Gateway

Add one secure layer between your agents and this server.

TDQS

A3.9/5.0
Disambiguation3/5

Several tools share the same basic purpose: ask_pipeworx, ask_pipeworx_beta, ask_pipeworx_grounded, and deep_research all route questions to data sources, and ask_pipeworx_beta is currently identical to ask_pipeworx. The polymarket_* family has five overlapping tools (edges, arbitrage, edge_tracker, fill_risk, kalshi_spread), though detailed descriptions and explicit 'use when' guidance help separate them. Overall, an agent can generally pick the right tool but faces real ambiguity in the query-router and betting clusters.

Naming Consistency4/5

Most tools follow a clear verb_noun snake_case convention (search, get_contents, resolve_entity, validate_claim, subscribe, unsubscribe). However, several noun-first names break the pattern: entity_profile, ai_visibility_check, pipeworx_feedback, pipeworx_trending, and the polymarket_* family, plus adjective-noun names like recent_alerts and recent_changes. The deviations are readable and mostly clustered around product-specific domains, so the inconsistency is minor.

Tool Count2/5

At 34 tools, this significantly exceeds the 25+ threshold for a heavy tool surface. The server bundles four distinct domains — web search, structured data routing, prediction-market analysis, and memory/subscriptions — into one MCP endpoint, which inflates the count. While each domain has some justification, a more focused split into separate servers would yield better coherence.

Completeness4/5

The surface is remarkably thorough for its blended scope: search has query/retrieve/similar/within, structured data has default/grounded/beta/deep-research modes, subscriptions have full lifecycle coverage, and memory has save/recall/delete. Minor gaps exist, such as no subscription-update tool and no direct pipeworx:// URI reader in the tool list, but these are workable. The prediction-market and entity-analysis workflows are covered end to end.

Resources